These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 834154)

  • 1. Partial body calcium measurements on patients with renal failure.
    Harrison JE; McNeill KG; Meema HE; Oreopoulos D; Rabinovich S; Fenton S; Wilson DR
    Metabolism; 1977 Mar; 26(3):255-65. PubMed ID: 834154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The investigation and treatment of renal bone disease.
    Catto GR; MacLeod M
    Am J Med; 1976 Jul; 61(1):64-73. PubMed ID: 937372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of radial bone mineral content with total body calcium in chronic renal failure.
    Cohn SH; Ellis KJ; Caselnova RC; Asad SN; Letteri JM
    J Lab Clin Med; 1975 Dec; 86(6):910-9. PubMed ID: 1194756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial-body calcium measurements by in vivo neutron activation analysis: comparisons with x-ray photodensitometry measurements of the radius.
    Harrison JE; McNeill KG; Meema HE; Fenton S; Oreopoulos DG; Sturtridge WC
    J Nucl Med; 1974 Nov; 15(11):929-34. PubMed ID: 4420966
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-body in-vivo neutron activation analysis in assessing treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
    Naik RB; Gosling P; Price CP; Robinson BH; Dabek JT; Heath DA; James HM; Kanis JA; Smith R
    Br Med J; 1976 Jul; 2(6027):79-83. PubMed ID: 1276820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo analysis of calcium content by localized neutronic radioactivation using a source of californium 252. Value in renal osteodystrophy].
    Zech P; Guey A; Leitienne PH; Meary MF; Pozet N; Moskovtchenko JF; Traeger J
    J Urol Nephrol (Paris); 1976; 82(4-5):315-9. PubMed ID: 781302
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of whole body calcium in chronic renal failure: effects of 1alpha-hydroxyvitamin D3 and parathyroidectomy.
    Naik RB; Dabek JT; Heynen G; James HM; Kanis JA; Robertson PW; Robinson BH; Woods CG
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():139s-145s. PubMed ID: 564247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased bone mineral content in young adults with familial hypophosphatemic vitamin D refractory rickets.
    Harrison JE; Cumming WA; Fornasier V; Fraser D; Kooh SW; McNeill KG
    Metabolism; 1976 Jan; 25(1):33-40. PubMed ID: 173975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies with quantitative computed tomography and dual-energy x-ray absorptiometry on bone density in renal osteopathy].
    Funke M; Mäurer J; Grabbe E; Scheler F
    Rofo; 1992 Aug; 157(2):145-9. PubMed ID: 1515623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutron activation analysis of a hand-a method of monitoring progressive bone disease.
    McIntosh JA; Catto GR
    Biomed Eng; 1974 Jun; 9(6):254-6 passim. PubMed ID: 4837582
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium loss in renal osteodystrophy as measured by neutron activation analysis.
    Catto GR; McIntosh JA; MacLeod M
    Proc Eur Dial Transplant Assoc; 1973; 10(0):173-81. PubMed ID: 4802414
    [No Abstract]   [Full Text] [Related]  

  • 13. Skeletal mass in long term hemodialysis patients.
    Letteri J; Nagwani P; Cohn S
    Adv Exp Med Biol; 1986; 208():305-11. PubMed ID: 3565153
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some biochemical, histological, radiological and clinical features of renal osteodystrophy.
    Eastwood JB; Bordier PJ; de Wardener HE
    Kidney Int; 1973 Aug; 4(2):128-40. PubMed ID: 4583084
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone lead in dialysis patients.
    Van de Vyver FL; D'Haese PC; Visser WJ; Elseviers MM; Knippenberg LJ; Lamberts LV; Wedeen RP; De Broe ME
    Kidney Int; 1988 Feb; 33(2):601-7. PubMed ID: 3129611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.
    Ritz E; Krempien B; Mehls O; Malluche H
    Kidney Int; 1973 Aug; 4(2):116-27. PubMed ID: 4790866
    [No Abstract]   [Full Text] [Related]  

  • 18. Deranged Ca, Al and Mg content in the tissues of patients with chronic renal failure, as measured by non-destructive neutron activation analysis.
    Marumo F; Nakamura M; Sato N; Shimada H; Tsukamoto S; Iwanami S
    Int J Artif Organs; 1985 Nov; 8(6):319-24. PubMed ID: 4077290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A system for in vivo measurement of bone calcium by local neutron activation of the hand.
    Ebifegha ME; Harrison JE; McNeill KG; Krishnan SS; Ssengabi J
    Int J Rad Appl Instrum A; 1986; 37(2):159-64. PubMed ID: 3019928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.